Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Australia
Clinical trial register · Australia

Clinical Trials in Australia

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3370 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
3370
Studies in scope
all four open statuses
1816
Recruiting now
open to new participants
776
Lead sponsors
across recruiting studies
Top sites
Melbourne 1109 Adelaide 582 Sydney 520 Westmead 421 Clayton 411
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca144 Merck Sharp & Dohme LLC109 Novartis Pharmaceuticals89 Janssen Research & Development, LLC80 Hoffmann-La Roche79 AbbVie72 Eli Lilly and Company66 Bristol-Myers Squibb55 GlaxoSmithKline53 Pfizer52 Sanofi46 Amgen46 Murdoch Childrens Research Institute37 Boehringer Ingelheim35 BeOne Medicines35 Peter MacCallum Cancer Centre, Australia30 Gilead Sciences29 University of Sydney29 Novo Nordisk A/S28 Children's Oncology Group28 Monash University25 Regeneron Pharmaceuticals25 Takeda24 University of Melbourne21 BioNTech SE19 Show all 1111
Site location
Melbourne1109 Adelaide582 Sydney520 Westmead421 Clayton411 Nedlands381 Brisbane355 Camperdown348 Parkville320 South Brisbane313 Perth299 Heidelberg273 Darlinghurst246 Woolloongabba239 Randwick210 St Leonards198 Liverpool195 Murdoch188 Fitzroy176 Kogarah162 Box Hill157 Southport154 Bedford Park154 Wollongong149 Herston143 Show all 396
All 396 locations
Target enrolment
to

Trials in this register

3370 of 3370 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
DualityBio Inc.
Phase 2
750
North Sydney, Benowa, Birtinya, Adelaide
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Westmead, Heidelberg, Melbourne
2025-07-17
Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
NCT06974110Advanced Solid Tumor, Metastatic Solid Tumor, Endometrial Cancer, MSI-H Cancer
DrugIrinotecan
MOMA Therapeutics
Phase 1
132
Sydney, Westmead, Woolloongabba, Adelaide, Clayton, Perth
2025-07-16
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
DrugsUplizna·Inebilizumab·Blinatumomab
Amgen
Phase 2
220
Perth
2025-07-16
Recruiting
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT07075185Multiple Myeloma in Relapse, Myeloma Multiple, Multiple Myeloma Progression, Neoplasms by Histologic Type
Kelonia Therapeutics, Inc.
Phase 1
70
Camperdown, Melbourne
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Wollongong, Birtinya, Clayton, St Albans
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 2
340
Kogarah, Macquarie Park, Ivanhoe, Malvern
2025-07-16
By invitation
TANDem-2: Closing the Gap to Interventions for TAND
NCT06879665Adult Caregivers of Individuals With TSC, Tuberous Sclerosis Complex (TSC)
Vrije Universiteit Brussel
Not applicable
30
Beverly Hills
2025-07-15
Recruiting
Takeda
Phase 3
347
Liverpool, Milton, Box Hill, Clayton, St Albans
2025-07-15
Recruiting
Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-Deficiency
NCT07928388Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Medicure
Phase 3
10
Brisbane, Melbourne
2025-07-15
Recruiting
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
NCT06175104Heart Defects, Congenital, Anxiety in Pregnancy, Depression, Postpartum, Trauma, Psychological
Children's Hospital Medical Center, Cincinnati
Not applicable
50
Randwick, Westmead
2025-07-14
Recruiting
Bristol-Myers Squibb
Phase 3
586
Kogarah, Macquarie Park, Carlton, Perth, Darlinghurst
2025-07-14
Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
NCT06838676Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG, Refractory DIPG, Recurrent DIPG
DrugACT001
Nationwide Children's Hospital
Phase 2
60
Randwick, South Brisbane, Melbourne, Perth
2025-07-10
Active, closed
Praxis Precision Medicines
Phase 3
160
Heidelberg
2025-07-09
Recruiting
ELEVATE-HFpEF Clinical Study
NCT06678841Heart Failure With Preserved Ejection Fraction (HFpEF)
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
700
Chermside, Melbourne
2025-07-09
Recruiting
Steps Against the Burden of Parkinson's Disease
NCT07057219Parkinson Disease (PD)
The University of New South Wales
Not applicable
42
Randwick
2025-07-09
Recruiting
Australasian Gastro-Intestinal Trials Group
Not applicable
30
Darlinghurst, Melbourne
2025-07-07
Active, closed
Sanofi
Phase 2
105
Brisbane, Clayton, Murdoch
2025-07-07
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Adelaide, Clayton
2025-07-07
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Macquarie University
2025-07-03
Active, closed
Novartis Pharmaceuticals
Phase 2
138
Darlinghurst, Adelaide, Melbourne
2025-07-03
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Adelaide, Bedford Park, Box Hill, Chermside, Darlinghurst, Joondalup, Liverpool, Westmead
2025-07-02
By invitation
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
NCT07038447Systemic Lupus Erythematosus, Lupus Nephritis, Systemic Sclerosis, Idiopathic Inflammatory Myopathy
DrugsKITE-363·Fludarabine·Cyclophosphamide
Kite, A Gilead Company
Phase 1
52
Syndey, Fitzroy
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Camperdown, Darlinghurst, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg
2025-07-02
Active, closed
European Myeloma Network B.V.
Phase 2
30
Adelaide, Sydney
2025-07-02
Recruiting
Akeso
Phase 1
48
Sydney
2025-07-02
Recruiting
Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy
NCT07028528Diabetic Peripheral Neuropathy
RDC Clinical Pty Ltd
Phase 2
80
Fortitude Valley
2025-07-01
Recruiting
Cosmetique Active International
Not applicable
80
Camperdown
2025-07-01
Not yet open
CPAP and Glucose Metabolism in Non-Diabetic OSA Subjects
NCT05335083Obstructive Sleep Apnea, Pre-diabetes
Woolcock Institute of Medical Research
Not applicable
100
Camperdown, Macquarie Park
2025-07-01
Recruiting
Woolcock Institute of Medical Research
Early Phase 1
10
Macquarie Park
2025-07-01
Not yet open
Menicon Co., Ltd.
Not applicable
220
Hillsdale, Sydney, Kelvin Grove, Carlton
2025-07-01
Recruiting
Benobio Co., Ltd.
Phase 1
18
Sydney
2025-07-01
Recruiting
Optimal Implementation of Antimicrobial Stewardship in General Practice
NCT06953804The Use of Antimicrobial Stewardship in in General Practice (Family Medicine), Respiratory Tract Infections (RTI)
University of Wollongong
Not applicable
120
Wollongong, Gold Coast, Hobart, Melbourne
2025-07-01
Recruiting
Novartis Pharmaceuticals
Phase 3
940
Darlinghurst, Adelaide, Malvern, Murdoch
2025-07-01
Not yet open
University of Melbourne
Phase 1
2
Melbourne
2025-07
Not yet open
Use of Water Ingestion in Small Intestine Ultrasound
NCT07079007Crohn Disease (CD), Intestine Ultrasonography
Austin Health
Observational
55
Heidelberg
2025-07
Recruiting
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 1
40
Brisbane, Melbourne
2025-06-30
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Camperdown, North Ryde, Westmead, Clayton
2025-06-30
Recruiting
AbbVie
Phase 1/2
602
Coffs Harbour, Port Macquarie, Westmead, South Brisbane, Adelaide, Fitzroy, Melbourne, West Perth
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
72
North Adelaide, Parkville
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Concord, Brisbane, Adelaide, Bedford Park, Hobart, Clayton, Murdoch
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
147
North Adelaide, Parkville
2025-06-30
Not yet open
Zhejiang Wenda Pharma Technology LTD.
Phase 1
68
Melbourne
2025-06-30
Recruiting
Marea Therapeutics
Phase 2
316
Canberra, Kanwal, Merewether, Miranda, Wollongong, Herston, Milton, Leabrook
2025-06-30
Active, closed
Azafaros B.V.
Phase 3
75
North Adelaide
2025-06-30
Active, closed
Pfizer
Phase 1/2
74
Blacktown, Brisbane, St Albans
2025-06-30
Not yet open
University of Adelaide
Not applicable
16
Adelaide
2025-06-28
Recruiting
AstraZeneca
Phase 2
987
Cairns, Nedlands, Norwood, Osborne Park, South Brisbane, Wollongong
2025-06-27
Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06995677Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations, FGFR3 Gene Alteration
DrugTYRA-300
Tyra Biosciences, Inc
Phase 2
90
Richmond
2025-06-27
Active, closed
University of Melbourne
Phase 1
32
Melbourne
2025-06-27
Recruiting
Monash Medical Centre
Phase 2
24
Clayton
2025-06-27
Recruiting
Neuroscience Research Australia
Not applicable
392
Sydney
2025-06-26
Recruiting
Telethon Kids Institute
Phase 4
200
Perth
2025-06-25
Recruiting
Domain Therapeutics Australia Pty Ltd
Phase 1/2
125
North Ryde, Adelaide, Frankston, Malvern, Nedlands
2025-06-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Garran, Liverpool, St Leonards, Auchenflower, Birtinya, Herston, Milton, Southport
2025-06-25
Recruiting
University of Sydney
Observational
15
Saint Leonards
2025-06-25
Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT07020221Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer, Colorectal Cancer, Solid Tumor, Adult
DrugsVS-7375·Repaglinide·Defactinib·Erbitux
Verastem, Inc.
Phase 1/2
616
Sydney, Frankston
2025-06-24
Recruiting
Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance
NCT06894875Exercise, Blood Pressure, Vasodilation, Vascular Function in Healthy Volunteers
Nuritas Ltd
Not applicable
48
Melbourne
2025-06-24
Active, closed
DBV Technologies
Phase 3
480
Westmead, South Brisbane, Parkville, Richmond, Nedlands
2025-06-24
Recruiting
XII Medical
Not applicable
30
Canberra, Sydney, Wollongong, Brisbane, Perth
2025-06-24
Recruiting
GlaxoSmithKline
Phase 3
961
Coffs Harbour, Maroubra, Westmead, Midland
2025-06-23
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Melbourne, Parkville, Liverpool, St Leonards
2025-06-23
Recruiting
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
NCT07082803Lymphoma, Lymphoma, Non Hodgkin
DrugZeprumetostat
Treeline Biosciences, Inc.
Phase 1
180
Macquarie Park, Woolloongabba, Malvern, Melbourne, Perth
2025-06-23
Recruiting
A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NCT07006233Idiopathic Hypersomnia, Narcolepsy Type 1 (NT 1), Narcolepsy Type 2 (NT2)
University of Sydney
Not applicable
30
Macquarie Park
2025-06-23
Recruiting
Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists
NCT06839248Residual Gastric Contents, Pulmonary Aspiration of Gastric Contents
St Vincent's Hospital Melbourne
Not applicable
154
Melbourne
2025-06-20
By invitation
BioMarin Pharmaceutical
Phase 3
140
Parkville
2025-06-20
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Sydney, Warrawong, Brisbane, Douglas, Southport, Box Hill, Geelong, Parkville
2025-06-19
Recruiting
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
60
Adelaide, Bayswater
2025-06-18
Active, closed
Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
NCT06984094RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection
Clover Biopharmaceuticals AUS Pty
Phase 1/2
612
Adelaide, Melbourne, Perth
2025-06-18
Recruiting
Inmagene LLC
Phase 2
405
Woden, Liverpool, Benowa, Carlton, Mitcham
2025-06-17
Recruiting
BlueRock Therapeutics
Phase 3
102
Randwick, Southport, Woolloongabba, Clayton, Melbourne, Parkville
2025-06-17
Active, closed
Arrowhead Pharmaceuticals
Phase 3
70
Camperdown, Saint Leonards, Heidelberg, Nedlands
2025-06-17
Active, closed
Atridia Pty Ltd.
Phase 1
25
Sydney, Adelaide, Brisbane, Melbourne, Perth, Wollongong
2025-06-15
Recruiting
SMSbiotech
Phase 1
18
Melbourne
2025-06-13
Recruiting
Relay Therapeutics, Inc.
Phase 2
277
Randwick, South Brisbane, Clayton, Parkville
2025-06-13
Recruiting
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
15
Adelaide
2025-06-12
Recruiting
The University of Western Australia
Observational
100
Perth
2025-06-12
Recruiting
GlaxoSmithKline
Phase 1/2
346
Heidelberg, Melbourne
2025-06-11
Recruiting
BeOne Medicines
Phase 3
630
Blacktown, Kogarah, Lismore, North Ryde, St Leonards, Birtinya, Woolloongabba, Clayton
2025-06-11
Recruiting
Study of HX15001 in Adult Healthy Volunteers.
NCT06999720Healthy Volunteers
DrugHX15001
Helixon Biotechnology (Suzhou) Co., Ltd
Phase 1
62
Herston
2025-06-11
Recruiting
Bristol-Myers Squibb
Phase 3
274
St Leonards, Brisbane
2025-06-11
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Melbourne
2025-06-10
Active, closed
PolyActiva Pty Ltd
Phase 1
12
Doncaster, Melbourne
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Adelaide, Clayton, Gosford, Melbourne, Nowra, Saint Albans, South Brisbane, Wollongong
2025-06-10
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
156
South Brisbane, Heidelberg, Nedlands, Randwick
2025-06-10
Active, closed
Biogen
Phase 3
255
Randwick, Parkville
2025-06-09
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Liverpool, Melbourne, Fremantle
2025-06-09
Recruiting
Celgene
Phase 2
120
Macquarie Park, Daw Park, Nedlands, Darlinghurst
2025-06-09
Recruiting
Calico Life Sciences LLC
Phase 2
240
Westmead, Brisbane, Adelaide, Murdoch
2025-06-09
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Recruiting
Clinical Hub for Interventional Research (CHOIR)
Observational
25
Canberra, Sydney, Westmead
2025-06-06
Active, closed
Effects of Chestnuts on Postprandial Glycaemic Response
NCT06960967Postprandial Glycemia, Insulin Resistance
Monash University
Not applicable
15
Melbourne
2025-06-06
Recruiting
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,400
Camperdown, Gateshead, North Sydney, Westmead, Adelaide, Clayton, Melbourne
2025-06-06
Recruiting
Celgene
Phase 2
200
Newcastle, Sydney, Kent Town, Hobart, Box Hill, Heidelberg, Parkville, Nedlands
2025-06-05
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bedford Park, Camperdown, Fitzroy, Kogarah, Melbourne, Woolloongabba
2025-06-04
Active, closed
Apogee Therapeutics, Inc.
Phase 1
86
Darlinghurst, Kogarah, Westmead, Woolloongabba, Carlton, East Melbourne, Mitcham, Parkville
2025-06-04
Recruiting
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
NCT06891443Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Sensation Disorders
DrugSepofarsen
Laboratoires Thea
Phase 3
32
Sydney
2025-06-04
Recruiting
Sagimet Biosciences Inc.
Phase 1
152
Botany, Darlinghurst, Camberwell, Melbourne, Fremantle
2025-06-03
Recruiting
Sanofi
Phase 2
99
Brisbane, Kurralta Park, Footscray
2025-06-03
Active, closed
Boston Scientific Corporation
Not applicable
376
New Lambton Heights, Westmead, Brisbane, Clayton, Parkville, Melbourne
2025-06-03
Recruiting
Digitally Delivered Treatments to Reduce Chronic Low Back Pain
NCT06984354Low Back Pain, Chronic Pain (Back / Neck), General Practice (GP), Primary Care Settings, Digital Health
Neuroscience Research Australia
Not applicable
720
Randwick
2025-06-02
Recruiting
Odyssey Therapeutics, Inc.
Phase 2
57
Birtinya, Box Hill, Maroochydore, Melbourne, Murdoch, Parkville
2025-06-02
Recruiting
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
NCT07063875Uveal Melanoma, Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver
DrugAldesleukin
St Vincent's Hospital, Sydney
Phase 1/2
8
Sydney, Melbourne
2025-06-01
Not yet open
University of Adelaide
Phase 2
25
Adelaide
2025-06-01
Recruiting
The University of New South Wales
Not applicable
60
Sydney
2025-06-01
Not yet open
Rehabilitation in the Home After Hip Fracture
NCT06980129Hip Fractures (ICD-10 72.01-72.2), Rehabilitation Program
South West Sydney Local Health District
Not applicable
220
Sydney
2025-06-01
Not yet open
Oragenics, Inc.
Phase 2
40
Melbourne
2025-06-01
Recruiting
Design Therapeutics, Inc.
Phase 1/2
20
Sydney, East Melbourne, Melbourne
2025-06
Recruiting
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
NCT06961565NF1 Mutation, Neurofibroma Plexiform, Neurofibroma, Plexiform, Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)
DrugPAS-004
Pasithea Therapeutics Corp.
Phase 1
56
St Leonards, Melbourne
2025-05-30
Recruiting
National Cancer Institute (NCI)
Phase 2
222
Hunter Regional Mail Centre, South Brisbane, Parkville, Perth
2025-05-30
Active, closed
Merck Sharp & Dohme LLC
Phase 2
160
Blacktown, Wollstonecraft, Nedlands
2025-05-29
Active, closed
Paradigm Biopharmaceuticals Ltd.
Phase 3
466
Brookvale, Charlestown, Miranda, Wollongong, South Brisbane, Southport, Adelaide, Stepney
2025-05-29
Recruiting
AbbVie
Phase 2
110
Blacktown, Lambton Heights, Brisbane, Chermside, Ballarat, Clayton, Nedlands
2025-05-28
Active, closed
AstraZeneca
Phase 3
3,103
Coffs Harbour, Ipswich, Joondalup, Leabrook, Liverpool, Maroubra, Melbourne, Woolloongabba
2025-05-28
Recruiting
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
Phase 1
12
Sydney
2025-05-27
Active, closed
Skyhawk Therapeutics, Inc.
Phase 2/3
120
New Lambton Heights, Westmead, Herston, Adelaide, Launceston, Caulfield South, Parkville, Nedlands
2025-05-27
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Murdoch, Concord, Heidelberg, Liverpool, Melbourne, South Brisbane, Woolloongabba
2025-05-27
Active, closed
An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant Recipients
NCT06867380Cochlear Implant Recipients, Hearing Loss, Cochlear
Cochlear
Not applicable
120
Carlton, East Melbourne
2025-05-27
Not yet open
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Phase 1
60
Melbourne
2025-05-27
Recruiting
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
NCT06921837Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
Bolt Biotherapeutics, Inc.
Phase 1/2
122
Darlinghurst, Westmead, Birtinya, Clayton, Heidelberg
2025-05-26
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Sydney, Brisbane, Parkville
2025-05-26
Recruiting
Tafalgie Therapeutics
Phase 1
94
Adelaide
2025-05-23
Recruiting
Analysis of Long-term Outcomes of Endoscopic Resection of Duodenal and Ampullary Mucosal and Submucosal Lesions
NCT07781137Duodenal Adenoma, Duodenal Carcinoma, Papillary Adenoma, Papillary Adenocarcinoma
Western Sydney Local Health District
Observational
1,000
Sydney
2025-05-23
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Kogarah, Brisbane, Clayton, Fitzroy
2025-05-22
Recruiting
Biogen
Phase 3
180
Concord, Kogarah, Liverpool, Westmead, Douglas, Herston, Southport, Clayton
2025-05-22
Recruiting
University of Adelaide
Not applicable
8
Adelaide
2025-05-22
Recruiting
Eikon Therapeutics
Phase 2/3
740
Wollongong, Chermside, Bedford Park, Box Hill, Frankston
2025-05-22
Recruiting
Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?
NCT06940596Irritable Bowel Syndrome (IBS), Intestinal Diseases, Gastrointestinal Disease
University of Melbourne
Not applicable
235
Melbourne
2025-05-22
Recruiting
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
NCT06847282Muscular Dystrophy, Facioscapulohumeral
University of Kansas Medical Center
Observational
80
Melbourne
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Blacktown, Brisbane, Melbourne, Nedlands
2025-05-22
Active, closed
Alkermes, Inc.
Phase 2
126
Sydney, Bedford Park, Clayton
2025-05-22
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
NCT06876649Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
DrugPirtobrutinib
Eli Lilly and Company
Phase 4
787
Adelaide, Melbourne, Victoria
2025-05-20
Recruiting
Eli Lilly and Company
Phase 4
279
Adelaide, Melbourne, Victoria
2025-05-20
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Adelaide, Brisbane, Camperdown, Murdoch
2025-05-19
Recruiting
Penumbra Inc.
Observational
300
Bedford Park, Sydney
2025-05-18
Active, closed
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT06970847Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent, Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Drug64Cu-SAR-bisPSMA
Clarity Pharmaceuticals Ltd
Phase 3
220
Darlinghurst, Wahroonga, Westmead, Herston
2025-05-16
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Chermside, Elizabeth Vale, Heidelberg, Hong Kong, Kogarah, Macquarie University, Murdoch, Port Macquarie
2025-05-15
Active, closed
Boehringer Ingelheim
Phase 1
91
Gosford, Geelong
2025-05-14
Active, closed
Juvena Therapeutics
Phase 1
72
Melbourne
2025-05-14
Recruiting
Dizal Pharmaceuticals
Phase 1
140
Blacktown, Camperdown
2025-05-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Blacktown, Macquarie University, Greenslopes, Melbourne, Murdock
2025-05-13
Recruiting
World Health Research Inc.
Observational
290
St Leonards, Chermside, Spring Hill, Melbourne, Murdoch
2025-05-13
Active, closed
University of Aarhus
Phase 1/2
32
Melbourne
2025-05-13
Recruiting
Woolcock Institute of Medical Research
Phase 2
20
Macquarie Park
2025-05-13
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Darlinghurst, Murdoch, Westmead, Woolloongabba
2025-05-12
Recruiting
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
NCT06924021Age-Related Macular Degeneration
University of Wisconsin, Madison
Observational
1,000
Adelaide
2025-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Camperdown, Westmead, Auchenflower, Melbourne
2025-05-12
Active, closed
Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.
NCT06888687Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Measurement, Dietary Modification
Australian Catholic University
Not applicable
160
Melbourne
2025-05-12
Recruiting
Hoffmann-La Roche
Phase 3
425
Macquarie Park, Wahroonga, Mackay, Adelaide, Footscray, Parkville
2025-05-12
Recruiting
Arrowhead Pharmaceuticals
Phase 1/2
150
Morayfield, Nedlands
2025-05-09
Recruiting
Bambusa Therapeutics
Phase 1
286
Perth, Brisbane
2025-05-08
Active, closed
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
NCT06907875Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc.
Phase 1/2
12
Sydney
2025-05-08
Recruiting
SURGE Therapeutics
Phase 1
18
Melbourne N.
2025-05-08
Recruiting
Biogen
Phase 3
454
New Lambton, New South Wales, St Leonards, Westmead, Douglas, Herston, Southport, Woolloongabba
2025-05-08
Recruiting
Monash University
Phase 2/3
900
Adelaide, Melbourne
2025-05-07
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
Not applicable
100
East Melbourne
2025-05-07
Recruiting
CorWave LVAS FIH Study
NCT06907017Advanced Heart Failure
CorWave
Not applicable
20
Sydney, Melbourne
2025-05-06
Recruiting
Monash University
Phase 2/3
900
Adelaide, Melbourne
2025-05-06
Recruiting
Monash University
Phase 2/3
900
Adelaide, Melbourne
2025-05-06
Recruiting
Takeda
Phase 3
225
Garran, Sydney, Douglas, Adelaide, Box Hill, Fitzroy, Melbourne, Parkville
2025-05-06
Recruiting
LaNova Medicines Limited
Phase 1/2
87
Ryde, Wollongong, Perth
2025-05-06
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Blacktown, Camperdown, Kogarah, Waratah, South Brisbane, Melbourne, Perth
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Camperdown, Clayton, Heidelberg, Randwick, South Brisbane
2025-05-06
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Melbourne
2025-05-05
Active, closed
Mediar Therapeutics
Phase 2
168
Melbourne, Midland, Westmead
2025-05-05
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Adelaide, Birtinya, Brisbane, Douglas, Melbourne, Perth, Sydney
2025-05-05
Recruiting
TRex Bio, Inc.
Phase 1
115
Deakin, Albion, Blacktown, Kanwal, Coorparoo, Adelaide, Melbourne, Saint Albans
2025-05-02
Recruiting
BioNTech SE
Phase 1/2
594
Camperdown, Bedford Park, Bendigo, Geelong, Saint Albans, Subiaco
2025-05-02
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329Progressive Pulmonary Fibrosis, Interstitial Lung Disease
University of Massachusetts, Worcester
Observational
500
Camperdown, Brisbane, Melbourne
2025-05-01
Recruiting
Monash University
Not applicable
100
Ararat, Ballarat, Beaufort, Daylesford, Maryborough, Nhill, Saint Arnaud, Warracknabeal
2025-05-01
Recruiting
SPYRAL GEMINI Pilot Study
NCT06907147Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
175
Perth
2025-05-01
Recruiting
Kiora Pharmaceuticals, Inc.
Phase 2
28
Sydney, Westmead, Adelaide, Hobart, East Melbourne, Nedlands
2025-05-01
Not yet open
Carl Zeiss Meditec AG
Observational
75
Melbourne, Craigie
2025-05
Not yet open
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
40
Adelaide
2025-05
Recruiting
Hoffmann-La Roche
Phase 1
405
Darlinghurst, Parkville
2025-04-30
Recruiting
Gilead Sciences
Phase 1/2
100
Darlinghurst, Birtinya, Tugun
2025-04-30
By invitation
Novo Nordisk A/S
Not applicable
36,000
Logan
2025-04-30
Recruiting
Eikon Therapeutics
Phase 1/2
130
Frankston
2025-04-30
Recruiting
Region Skane
Observational
1,500
Brisbane
2025-04-28
By invitation
Vertex Pharmaceuticals Incorporated
Phase 2
44
Auchenflower, Melbourne
2025-04-28
Recruiting
Monash University
Phase 2/3
900
Adelaide, Melbourne
2025-04-28
Recruiting
AbbVie
Phase 2
390
Sydney, South Brisbane, Woodville South, Heidelberg, Nedlands
2025-04-24
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Canberra, North Tamworth, Orange, Brisbane, Elizabeth Vale, Frankston, Melbourne, Traralgon
2025-04-24
Recruiting
Centervue SpA
Not applicable
380
Perth
2025-04-23
Recruiting
BioNTech SE
Phase 1/2
380
Adelaide, Box Hill, Fitzroy, Melbourne
2025-04-23
Recruiting
AP Biosciences Inc.
Phase 1/2
85
Macquarie, Bedford Park, Perth
2025-04-22
By invitation
QED Therapeutics, a BridgeBio company
Phase 2/3
24
Parkville
2025-04-22
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
DrugsCeftolozane-tazobactam·Cefiderocol·Fosfomycin·Meropenem-Vaborbactam
National University of Singapore
Phase 4
600
Brisbane
2025-04-21
Recruiting
AstraZeneca
Phase 1/2
150
Darlinghurst, Melbourne
2025-04-21
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.
Phase 2
340
Camperdown, Macquarie Park, Westmead, Brisbane, Woodville South, Melbourne, Chermside, Footscray
2025-04-17
Recruiting
Neurocrine Biosciences
Phase 3
850
Carlton, Melbourne
2025-04-16
Recruiting
ModernaTX, Inc.
Phase 2
180
Birtinya
2025-04-16
Recruiting
Austin Health
Not applicable
120
Melbourne
2025-04-16
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Clayton, Coorparoo, Greenslopes, Kogarah, Melbourne, Mitcham, Westmead
2025-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
605
St Albans
2025-04-15
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
NCT06401330Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor, Stage IV Mixed Cell Type Kidney Wilms Tumor
DrugsDactinomycin·Vincrystine·Cytoxan·Paraplatin
Children's Oncology Group
Phase 3
1,656
South Brisbane
2025-04-15
Recruiting
University of Sydney
Not applicable
319
Camperdown
2025-04-15
Recruiting
Benefits of Choir for Older Adults With Unaddressed Hearing Loss (WP2)
NCT06580847Hearing Loss, Age-Related, Speech Intelligibility, Psychosocial Functioning
Toronto Metropolitan University
Not applicable
210
Adelaide
2025-04-15
Recruiting
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06673017Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer
PanTher Therapeutics
Phase 1
26
Melbourne
2025-04-14
Recruiting
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
NCT06510699Fungal Infection, Haematological Malignancy, Blood Cancer, Infectious Disease
The University of Queensland
Phase 2
104
Sydney, Brisbane, South Brisbane, Adelaide, Melbourne
2025-04-14
Recruiting
University Health Network, Toronto
Observational
3,000
Sydney, Melbourne
2025-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
150
Darlinghurst, Fortitude Valley, Melbourne, Prahran
2025-04-14
Active, closed
ASCEND CSP IDE Study
NCT06830746Heart Failure, Ventricular Arrythmia
Abbott Medical Devices
Not applicable
414
Chermside, Woolloongabba, Adelaide, Clayton
2025-04-11
Recruiting
AstraZeneca
Phase 3
830
Hobart, Woolloongabba
2025-04-10
Recruiting
BeOne Medicines
Phase 3
250
Concord, Gosford, Port Macquarie, Randwick, Toowoomba, Bedford PK, Melbourne, West Perth
2025-04-10
Recruiting
ResMed
Not applicable
80
Bella Vista
2025-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Sydney, Brisbane, East Melbourne, Frankston
2025-04-09
Recruiting
Capstan Therapeutics
Phase 1
64
Herston, Bayswater, Nedlands
2025-04-09
Recruiting
Priovant Therapeutics, Inc.
Phase 2/3
168
Melbourne, Parkville
2025-04-09
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Box Hill, Clayton, Heidelberg Heights, Nedlands
2025-04-09
Recruiting
Hoffmann-La Roche
Phase 3
450
Blacktown, St Leonards, Elizabeth Vale, Clayton, Ringwood
2025-04-09
Recruiting
Bristol-Myers Squibb
Phase 3
194
Melbourne
2025-04-08
Active, closed
iQure Australia Pty Ltd
Phase 1
72
Adelaide
2025-04-08
Recruiting
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
NCT06714006Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PYC Therapeutics
Phase 1
166
Southport, Concord, Liverpool, Randwick, Wahroonga, Westmead, South Brisbane, Fitzroy
2025-04-07
Recruiting
A Phase I Study to Evaluate LIFE-001
NCT06904807Healthy Volunteers
LifeMine Therapeutics
Phase 1
160
Bayswater
2025-04-07
Recruiting
Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
NCT06962371Transcatheter Aortic Valve Implantation (TAVI), Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement
Transverse Medical, Inc.
Not applicable
30
Clayton
2025-04-07
Recruiting
Vifor Pharma, Inc.
Phase 2
36
Clayton, Parkville, Westmead
2025-04-06
Recruiting
Gilead Sciences
Phase 3
695
New South Wales, Queensland, Southport, Adelaide, Fitzroy, Nedlands
2025-04-04
Recruiting
A Phase 1 Study of S-4321
NCT06877611Healthy Volunteer
DrugS-4321
Seismic Therapeutic AU Pty Ltd
Phase 1
96
Bayswater
2025-04-03
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
DrugsRibociclib·Fulvestrant
Novartis Pharmaceuticals
Phase 1/2
280
Clayton, Melbourne
2025-04-03
Recruiting
Racura Oncology Ltd
Phase 1
53
Gosford, Miranda, Wyong
2025-04-02
Active, closed
TrueLab Biopharmaceutical Co., Ltd
Phase 1
64
Nedlands
2025-04-02
Recruiting
De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)
NCT06307015HPV Positive Oropharyngeal Squamous Cell Carcinoma
Royal North Shore Hospital
Not applicable
25
Saint Leonards
2025-04-01
Active, closed
Orygen
Phase 2
75
Parkville
2025-04-01
Active, closed
Testing a Digital Tool to Support Healthy Pregnancies
NCT06896292Preventive Behaviors, Antenatal Care and Delivery
Hunter and New England Health
Not applicable
372
Maitland, Taree
2025-04-01
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Maastricht University
Not applicable
358
Melbourne
2025-04-01
Recruiting
Maintenance rTMS for Depression (Maitr-De)
NCT06938841Major Depressive Disorder, Treatment Resistant Depression
University of California, San Diego
Not applicable
75
Canberra
2025-04-01
Not yet open
Functional Assessments in Vision Impairment
NCT06908161Retinitis Pigmentosa (RP), Diabetic Retinopathy (DR), Age Related Macular Degeneration (AMD), Glaucoma
Center for Eye Research Australia
Observational
45
Melbourne
2025-04-01
Recruiting
Tissue Repair Gel in Venous Leg Ulcers in AU/US
NCT06707103Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis
DrugGlucoprime
TR Therapeutics
Phase 3
312
Camperdown, Kogarah, Orange, Sydney, Bendigo, Ivanhoe, Shepparton, Nedlands
2025-04
Not yet open
Integrated Community Oncology Network
Not applicable
168
Wahroonga, Windsor Gardens
2025-04
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
50
Fitzroy, Maroochydore, Midland
2025-03-31
Not yet open
Predicting Outcomes Using Infra-red SEnsors, a Feasibility Study.
NCT06515080General Anesthetic Drug Adverse Reaction
Uppsala University
Observational
500
Perth
2025-03-31
Recruiting
Nimbus Wadjet, Inc.
Phase 1/2
134
Liverpool, Bedford Park
2025-03-31
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
683
Frankston
2025-03-31
Recruiting
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
NCT06917079Non-Small Cell Lung Cancer, NSCLC, PDAC - Pancreatic Ductal Adenocarcinoma, CRC (Colorectal Cancer)
DrugsBBO-10203·MFOLFIRINOX·MFOLFOX6·Cetuximab
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
665
Melbourne
2025-03-31
Recruiting
AbbVie
Observational
700
Kingswood, Waratah, Malvern
2025-03-28
Recruiting
Prescient Therapeutics, Ltd.
Phase 2
115
Westmead, Melbourne, Nedlands
2025-03-28
Recruiting
Phase 1 Study of Chlamydia Trachomatis mRNA Vaccine in Adults.
NCT06891417Chlamydia Trachomatis Immunization
Sanofi
Phase 1
80
Bruce, Maroubra, Sydney, Albion, Morayfield, Southport, Melbourne
2025-03-27
Recruiting
Sanofi
Phase 1
62
Melbourne
2025-03-27
Recruiting
AstraZeneca
Phase 3
600
Blacktown, East Melbourne, Nedlands, South Brisbane
2025-03-27
Active, closed
Generate Biomedicines
Phase 1
40
Herston
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Auchenflower, Birtinya, Heidelberg, Kurralta Park, North Tamworth, Perth, Shepparton, Traralgon
2025-03-27
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Sydney
2025-03-26
Recruiting
EMVision Medical Devices Ltd
Observational
300
Liverpool, Parkville
2025-03-26
Active, closed
Forte Biosciences, Inc.
Phase 1
64
Darlinghurst, Kotara, Coorparoo
2025-03-25
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2/3
150
Melbourne, Camperdown, Liverpool
2025-03-25
Recruiting
Bristol-Myers Squibb
Phase 1
437
Brisbane
2025-03-25
Recruiting
AstraZeneca
Phase 3
990
Coffs Harbour, Frankston, Garran, Nedlands, New Lambton, Spearwood, Wollongong, Woodville South
2025-03-25
Recruiting
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
NCT06855745Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis, Atopic Dermatitis (AD)
DrugZabalafin
Alphyn Biologics
Phase 2
72
Brookvale, Darlinghurst, Kogarah, Kotara, Waitara, Wollongong, Benowa, Wellers Hill
2025-03-25
Recruiting
ROADMAP Clinical Trial
NCT06771050Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections
University of Newcastle, Australia
Phase 4
2,500
Garran, Bankstown, Blacktown, Campbelltown, Camperdown, Caringbah, Gateshead, Kingswood
2025-03-24
Recruiting
Bayer
Phase 1/2
450
Camperdown, Concord, Epping, Waratah
2025-03-21
Active, closed
Immutep S.A.S.
Phase 3
756
Elizabeth Vale, Greenslopes, Melbourne, Southport, Subiaco, Tiwi, Waratah, Wollongong
2025-03-21
Active, closed
Janssen Research & Development, LLC
Phase 1
85
Concord, Melbourne, Nedlands
2025-03-21
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
Campbelltown, Melbourne, Murdoch
2025-03-20
Recruiting
Daiichi Sankyo
Phase 3
582
Adelaide, Auchenflower, Hobart, Perth, Richmond, St Leonards, Sydney, Townsville
2025-03-19
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Macquarie Park, Parkville, Woolloongabba
2025-03-18
Recruiting
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
NCT06803680Advanced Solid Tumor, Metastatic Solid Tumor
BeOne Medicines
Phase 1
90
Blacktown, Liverpool
2025-03-18
Recruiting
Hoffmann-La Roche
Phase 3
600
Garran, Sydney, Herston, South Brisbane, Woolloongabba, Adelaide, Epping, Murdoch
2025-03-17
Recruiting
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
72
Melbourne
2025-03-17
Recruiting
National Heart Centre Singapore
Observational
150
New Lambton Heights
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Blacktown, Frankston
2025-03-16
Recruiting
AstraZeneca
Phase 3
11,300
Adelaide, Castle Hill, Coffs Harbour, Elizabeth Vale, Fremantle, Geelong, Kingswood, Leabrook
2025-03-14
Active, closed
Hoffmann-La Roche
Phase 4
274
Strathfield, Sydney, Adelaide, East Melbourne, Rowville, Nedlands
2025-03-14
Active, closed
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Active, closed
AstraZeneca
Phase 2
82
East Melbourne, Wollongong, Woodville South
2025-03-12
Active, closed
Amgen
Phase 3
3,853
Botany, Charlestown, Miranda, St Leonards, Wollongong, Meadowbrook, Norwood, Oaklands Park
2025-03-12
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Camperdown, Liverpool, Brisbane, Adelaide, Clayton, Melbourne, Murdoch
2025-03-12
Recruiting
Iovance Biotherapeutics, Inc.
Phase 1/2
42
Greenslopes, Nedlands
2025-03-11
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Macquarie University, Perth
2025-03-11
Recruiting
AstraZeneca
Phase 1
136
East Melbourne
2025-03-10
Recruiting
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
NCT06528301Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL), Lymphoma, Large B-Cell, Diffuse (DLBCL), Chronic Lymphocytic Leukemia (CLL)
DrugsRapamycin·Sirolimus
Umoja Biopharma
Phase 1
106
Saint Leonards, Fitzroy
2025-03-10
Active, closed
Takeda
Phase 3
601
Camperdown, Westmead, Sippy Downs, Woodville South, Palmyra Dc, Victoria Park
2025-03-10
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
Clayton, Melbourne
2025-03-10
Recruiting
Melanoma Institute Australia
Phase 2
129
Westmead, Wollstonecraft, Woolloongabba, Melbourne
2025-03-06
Recruiting
Neurotech Pharmaceuticals
Phase 3
60
East Melbourne, Perth, Sydney
2025-03-06
Recruiting
AbbVie
Phase 1/2
252
Blacktown, Townsville, Elizabeth Vale, Frankston
2025-03-06
Recruiting
Hoffmann-La Roche
Phase 2
130
East Melbourne
2025-03-05
Recruiting
BeOne Medicines
Phase 3
300
Birtinya, Box Hill, Clayton, Cooloongup, West Perth
2025-03-05
Recruiting
Tyra Biosciences, Inc
Phase 2
92
Westmead, Parkville
2025-03-04
Recruiting
GlaxoSmithKline
Phase 1/2
305
Liverpool, Wollongong
2025-03-04
Recruiting
BioNTech SE
Phase 2
60
Liverpool, Woolloongabba, Adelaide, Hobart, Nedlands
2025-03-03
Recruiting
AstraZeneca
Phase 3
5,000
Adelaide, Darlinghurst, Elizabeth Vale, Gosford, North Tamworth, Perth, Southport, St Leonards
2025-03-03
Active, closed
BicycleTx Limited
Phase 2
66
Melbourne
2025-03-03
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Melbourne, Canberra, North Sydney, Perth, Sydney
2025-03-01
Recruiting
AstraZeneca
Phase 3
840
Darlinghurst, Heidelberg, Murdoch, Westmead
2025-03-01
Recruiting
Spinal Cord Injury Neurorecovery Collaboration
NCT06871254Spinal Cord Injuries
University of Melbourne
Not applicable
24
Heidelberg
2025-03-01
Not yet open
Neonatologist-Performed Lung Ultrasound (NPLUS) to Guide Respiratory Therapy
NCT06901206PreTerm Neonate, Respiratory Distress Syndrome (RDS)
Royal Hospital For Women
Not applicable
20
Sydney
2025-03
Not yet open
University Hospital, Antwerp
Observational
120
Perth
2025-03
Recruiting
A Phase 1 Study of S-1117
NCT06828393Healthy Volunteer
Seismic Therapeutic AU Pty Ltd
Phase 1
96
Adelaide
2025-03
Active, closed
Sanofi
Phase 2
84
Saint Leonards, Brisbane, Parkville
2025-02-28
Recruiting
Incyte Corporation
Phase 3
600
Charleston, Kogarah, Liverpool, Sydney, Woolloongabba, Melbourne, Fremantle, Westmead
2025-02-28
Recruiting
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
NCT06763055Intracerebral Hemorrhage, Spontaneous Intracerebral Hemorrhage, Supratentorial Intracerebral Haemorrhage, Acute Intracerebral Haemorrhage
DrugColchicine
The George Institute
Phase 3
2,000
Sydney
2025-02-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
327
Woolloongabba, Clayton
2025-02-27
Recruiting
Takeda
Phase 3
171
Garran, Concord, Kogarah, Liverpool, Westmead, Melbourne, Murdoch, West Perth
2025-02-27
Recruiting
Bambusa Therapeutics
Phase 1
237
Fremantle, Perth
2025-02-27
Recruiting
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
NCT06816992Solid Tumors, EGFR Exon 20 Insertion Mutations, NSCLC, EGFR-mutated NSCLC
DrugAmivantamab
ORIC Pharmaceuticals
Phase 1
76
Melbourne
2025-02-27
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
Darlinghurst, Herston, Melbourne
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Bedford Park, Clayton, Douglas, North Melbourne, St Leonards, Subiaco, Wollongong
2025-02-27
Active, closed
Cambridge University Hospitals NHS Foundation Trust
Phase 2
20
Melbourne, Richmond
2025-02-26
Recruiting
Comanche Biopharma
Phase 1
60
Parkville, Melbourne
2025-02-26
Recruiting
University of Auckland, New Zealand
Observational
125
Sydney
2025-02-26
Active, closed
Fusion Pharmaceuticals Inc.
Phase 2
85
Macquarie Park, Woolloongabba, Kurralta Park, Melbourne
2025-02-26
Active, closed
Amgen
Phase 2
252
Clayton, Heidelberg
2025-02-26
Recruiting
Vividion Therapeutics, Inc.
Phase 1
220
Adelaide, Nedlands
2025-02-25
Recruiting
Amgen
Phase 3
844
Woodville South
2025-02-25
Recruiting
Cyclarity Therapeutics, Inc.
Early Phase 1
84
Adelaide, Camberwell, Melbourne
2025-02-25
Recruiting
Bristol-Myers Squibb
Phase 3
530
Campbelltown, Penrith, Brisbane, Ballarat Central, Murdoch
2025-02-25
Recruiting
CStone Pharmaceuticals
Phase 1/2
800
Melbourne, South Brisbane, Sydney
2025-02-24
Recruiting
Capstan Medical TMVR Study: FIH
NCT06600191Mitral Regurgitation
Capstan Medical
Not applicable
10
Melbourne
2025-02-24
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Darlinghurst, Melbourne
2025-02-24
Recruiting
Akeso
Phase 1
100
Blacktown, North Ryde, South Brisbane, Frankston
2025-02-24
Recruiting
Gain Therapeutics, Inc.
Phase 1
20
Darlinghurst, Kogarah, Westmead, Woolloongabba, Adelaide, Melbourne, Parkville
2025-02-21
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Ipswich, Maroochydore, Parramatta, South Woodville, Tiwi
2025-02-21
Recruiting
Pikavation Therapeutics, Inc.
Phase 1/2
320
Camperdown, Randwick, Clayton, Melbourne, Nedlands
2025-02-20
Recruiting
Integrum
Not applicable
70
Melbourne
2025-02-19
Active, closed
Gilead Sciences
Phase 2
39
Sydney, Kurralta Park, Clayton, Melbourne
2025-02-18
Recruiting
Novo Nordisk A/S
Phase 3
510
Camperdown, Randwick, Clayton, Murdoch
2025-02-17
Recruiting
University of Sydney
Observational
15
St Leonards
2025-02-17
Recruiting
Voronoi, Inc
Phase 1
72
Darlinghurst
2025-02-17
Recruiting
A Study of DM002 in Patients With Advanced Solid Tumors
NCT06751329Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Colorectal Neoplasms
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
280
Randwick, Wollongong, Adelaide
2025-02-17
Recruiting
Bayer
Phase 2
111
Blacktown, Sydney, Southport
2025-02-13
Active, closed
Bristol-Myers Squibb
Phase 1/2
360
Southport
2025-02-12
By invitation
Longboard Pharmaceuticals
Phase 3
324
Randwick, Westmead, Brisbane, Heidelberg, Parkville
2025-02-12
Recruiting
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
NCT06824155HER2 Gene Mutation, Advanced Solid Tumors
Radiopharm Theranostics, Ltd
Early Phase 1
30
Kingswood, Macquarie Park, Wollongong, Fitzroy, Murdoch
2025-02-12
Active, closed
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd
Phase 2
100
Albury, Hurstville, Parramatta, Sydney, Westmead, Birtinya, Adelaide
2025-02-11
Recruiting
Locally Optimised Contouring With AI Technology for Radiotherapy
NCT06546592Contouring, Segmentation, Radiation Therapy, Artificial Intelligence
Royal North Shore Hospital
Not applicable
444
Dubbo, Orange, St Leonards
2025-02-11
By invitation
Western Sydney Local Health District
Observational
500
Sydney, Westmead, Nedlands
2025-02-10
Recruiting
Dianthus Therapeutics
Phase 3
256
Liverpool, Randwick, Saint Leonards, Sydney, Southport, Melbourne
2025-02-10
Recruiting
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1
234
Randwick, Sydney
2025-02-10
Active, closed
Rivermark Medical
Not applicable
215
Wollongong
2025-02-10
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Fitzroy
2025-02-07
Active, closed
Genmab
Phase 3
584
New Lambton Heights, South Brisbane, Subiaco
2025-02-07
Recruiting
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
NCT06754852Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2, Von Willebrand Disease (VWD), Type 3
Hemab ApS
Phase 1/2
108
Murdoch, Camperdown, Melbourne
2025-02-06
Active, closed
Sanofi
Phase 3
216
Bella Vista, Brisbane, Spearwood
2025-02-06
Recruiting
LEO Pharma
Phase 3
90
Darlinghurst, St Leonards, Westmead, Melbourne
2025-02-05
Recruiting
ARC101 in Advanced Solid Tumors
NCT06672185Advanced Solid Tumor
Third Arc Bio
Phase 1
70
Birtinya, Adelaide, Malvern
2025-02-05
Recruiting
BeOne Medicines
Phase 1
120
Darlinghurst, Waratah, Birtinya, Melbourne, St Albans, Nedlands
2025-02-04
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Liverpool, Woolloongabba, Melbourne, Subiaco
2025-02-04
Recruiting
BioNTech SE
Phase 3
621
Waratah, Wollongong, Cairns, Kurralta Park, Woodville, Frankston, Heidelberg, St Albans
2025-02-03
Recruiting
Study of Olutasidenib and Temozolomide in HGG
NCT06161974High Grade Glioma, Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV
DrugOlutasidenib
Rigel Pharmaceuticals
Phase 2
60
Randwick, South Brisbane, Perth
2025-02-01
Not yet open
Woolcock Institute of Medical Research
Not applicable
558
Sydney
2025-02-01
Recruiting
Sir Mortimer B. Davis - Jewish General Hospital
Observational
4,700
Melbourne
2025-02-01
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Box Hill, Parkville, Perth, Sydney
2025-02-01
Not yet open
University of Sydney
Not applicable
50
Royal Prince Alfred Hospital
2025-02
Not yet open
Design Therapeutics, Inc.
Phase 1
36
Melbourne
2025-02
Recruiting
Allotera Therapeutics
Phase 2
125
Melbourne
2025-01-31
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Phillip, Sydney, Westmead, Melbourne, Parkville
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Heidelberg, Melbourne, Nedlands
2025-01-30
Recruiting
Rezubio Pharmaceuticals Co., Ltd.
Phase 1
134
Adelaide
2025-01-30
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bedford Park, Kingswood, South Brisbane, Sydney
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Camperdown, Kingswood, Waratah, Southport, Tugun, Heidelberg, North Melbourne, Murdoch
2025-01-28
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugALKS 2680
Alkermes, Inc.
Phase 2/3
786
Sydney, Bedford Park, Clayton
2025-01-27
Active, closed
AbbVie
Phase 1
4
Sydney, Southport, Heidelberg, Perth
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Townsville, Adelaide, Ballarat, Melbourne, Perth
2025-01-27
Recruiting
University of Melbourne
Not applicable
25
Parkville
2025-01-24
Recruiting
BeOne Medicines
Phase 1/2
258
Blacktown, Adelaide, Malvern, Melbourne, Cooloongup, Nedlands
2025-01-23
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
NCT06789172Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer
DrugFamotidine
Epkin
Phase 1
146
Sydney, Perth
2025-01-23
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Blacktown, Cooloongup, Epping, Heidelberg, Kingswood, Liverpool, Melbourne, Perth
2025-01-22
Active, closed
Long-Term PEA Safety Study
NCT06717867Healthy, Safety
RDC Clinical Pty Ltd
Phase 2
200
Brisbane
2025-01-22
Recruiting
Implementing Surgery School Prehabilitation Using Telehealth
NCT06631872Adults Waiting to Undergo Lung Cancer or Major Abdominal, Open or Video Assisted Cancer Surgery
University of Melbourne
Not applicable
515
New Lambton Heights, Waratah, Southport, Woolloongabba, Burnie, Launceston, Heidelberg, Melbourne
2025-01-22
Recruiting
Cullinan Therapeutics Inc.
Phase 1
24
Parkville, Victoria Park
2025-01-21
Recruiting
Incyte Corporation
Phase 3
240
Sydney, Adelaide, Heidelberg
2025-01-21
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
100
Saint Leonards, Sydney, Tugun, Adelaide, Frankston
2025-01-21
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Sydney
2025-01-20
Recruiting
Presidio Medical, Inc
Not applicable
303
Norwood, Wayville, Clayton
2025-01-17
Active, closed
AbbVie
Phase 1
21
Fitzroy Melbourne, Nedlands
2025-01-16
Recruiting
Rigicon, Inc.
Not applicable
182
Auchenflower, Garran, Hornsby, Hurstville, Malvern, Miranda, Moorabbin
2025-01-16
Active, closed
argenx
Phase 3
631
Sydney, Woodville South, Clayton, Murdoch
2025-01-15
Not yet open
Baker Heart and Diabetes Institute
Not applicable
50
Melbourne
2025-01-15
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Camperdown, Penrith, St Leonards, Woolloongabba, Bedford Park, Hobart, Box Hill, Melbourne
2025-01-15
Active, closed
Intellia Therapeutics
Phase 3
80
Campbelltown, Melbourne, Parkville
2025-01-15
Active, closed
Stemline Therapeutics, Inc.
Phase 2
85
Concord, Douglas, Adelaide, Box Hill, Clayton, Fitzroy, Heidelberg, Perth
2025-01-14
Recruiting
BioNTech SE
Phase 1/2
248
Southport, Adelaide, Clayton, Randwick
2025-01-13
Recruiting
Fortvita Biologics (USA)Inc.
Phase 1
250
Wollongong, Adelaide
2025-01-10
Recruiting
BeOne Medicines
Phase 1
695
Blacktown, Woolloongabba, Clayton, Heidelberg, Nedlands
2025-01-10
Recruiting
Praxis Precision Medicines
Phase 2
50
Heidelberg, Melbourne
2025-01-10
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Ipswich, Maroochydore, South Woodville, St Leonards, Tiwi
2025-01-09
Recruiting
BlossomHill Therapeutics
Phase 1/2
675
Heidelberg, Melbourne
2025-01-09
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Kogarah, Campbelltown, Carlton, East Melbourne
2025-01-08
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke
Region Skane
Phase 4
3,500
Adelaide, Clayton, Sydney
2025-01-07
Recruiting
BioNTech SE
Phase 2/3
1,580
Adelaide, Bedford Park, Cairns, Dubbo, Frankston, Joondalup, Kurralta Park, Melbourne
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Douglas, Woolloongabba, Capel Sound, Frankston, Melbourne, Parkville
2025-01-06
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Adelaide, Bankstown, Box Hill, Coffs Harbour, Hobart, Kurralta Park, Traralgon, Waratah
2025-01-03
Recruiting
Regeneron Pharmaceuticals
Phase 3
369
Darlinghurst, Westmead, Woolloongabba, South Yarra, Fremantle
2025-01-02
Not yet open
Surgery and Reducing Ionizing Radiation of the Unknown Primary
NCT06578871Head and Neck Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2
90
Adelaide
2025-01-01
Recruiting
Defining Retinal Structures Using Hyperspectral Retinal Imaging
NCT07555574Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Diseases
Center for Eye Research Australia
Not applicable
1,000
Melbourne
2025-01-01
Active, closed
The CPR, Pre-hospital ECPR and Early Reperfusion Study: A Target Trial Emulation
NCT07679737Out of Hospital Cardiac Arrest, Extracorporeal Cardiopulmonary Resuscitation
Australian and New Zealand Intensive Care Research Centre
Observational
250
Melbourne
2025-01-01
Active, closed
Boehringer Ingelheim
Phase 2
90
Randwick, Woolloongabba
2024-12-30
Recruiting
HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
NCT06649708Advanced Solid Tumor Malignancies
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Phase 1/2
100
Blacktown, Auchenflower, Malvern
2024-12-30
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
216
Herston, Adelaide, Clayton, Fitzroy, Melbourne, Parkville, Nedlands
2024-12-30
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
Macquarie University, Melbourne, Nedlands, Randwick
2024-12-30
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
190
Westmead, Wollongong, Heidelberg
2024-12-30
Active, closed
Amgen
Phase 2
61
St Leonards, Waratah, South Brisbane, Adelaide
2024-12-26
Active, closed
Coherus Oncology, Inc.
Phase 2
72
Herston, Bankstown, Melbourne, Darlinghurst, Nedlands
2024-12-20
Recruiting
Therini Bio Pty Ltd
Phase 1
21
Parramatta, Sydney, Westmead, Woolloongabba, Adelaide, Albans, Malvern
2024-12-20
Recruiting
Sanofi
Phase 2
84
Garran, Parkville
2024-12-19
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
NCT06656494Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
DrugsMesutoclax·Azacitidine
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
266
Sydney, Perth
2024-12-18
Active, closed
argenx
Phase 3
154
Parkville, Southport, Sydney, Woolloongabba
2024-12-18
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Westmead, Brisbane, Southport, Parkville, Perth
2024-12-18
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Melbourne
2024-12-17
Active, closed
Arrowhead Pharmaceuticals
Phase 1
39
Sydney, Melbourne
2024-12-17
Recruiting
Replimune, Inc.
Phase 2/3
280
Wollstonecraft, Melbourne
2024-12-17
Recruiting
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Phase 1
123
Brisbane, Adelaide, Monash
2024-12-16
Recruiting
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
NCT06312644Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS)
DrugUltomiris
Alexion Pharmaceuticals, Inc.
Observational
75
Melbourne
2024-12-16
Active, closed
Kirby Institute
Phase 3
300
Sydney, Melbourne
2024-12-16
Recruiting
GlaxoSmithKline
Phase 3
520
Gosford NSW, Box Hill, Melbourne, Fitzroy, Herston, St Leonards
2024-12-16
Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
NCT06784193Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC), Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Breast Cancer
DrugsPalazestrant·Fulvestrant
Olema Pharmaceuticals, Inc.
Phase 1
180
Darlinghurst, Liverpool, Macquarie, Adelaide
2024-12-16
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
55
Melbourne
2024-12-16
Not yet open
Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure
NCT06681636HPV Infection, Cervical Cancer, Anogenital Cancer, Anogenital Warts
DrugHPV nonavalent vaccine
National Institute of Hygiene and Epidemiology, Vietnam
Phase 2
300
Parkville
2024-12-14
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Camperdown, Clayton, Murdoch, Wollongong
2024-12-13
Active, closed
GlaxoSmithKline
Phase 1/2
14
Melbourne
2024-12-13
Recruiting
GlaxoSmithKline
Phase 3
514
Fitzroy
2024-12-12
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Concord, Heidelberg, South Woodville, St Albans
2024-12-12
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Darlinghurst, Melbourne
2024-12-12
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
186
Sydney, Wollongong, Benowa, Adelaide, Melbourne
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 3
350
Macquarie Park, Parkville
2024-12-11
Recruiting
Basilea Pharmaceutica
Phase 3
450
Sydney, Woolloongabba, Melbourne, Parkville, Clayton
2024-12-11
Recruiting
SEALion: Study on Supplemental Oxygenation Via Nasal Cannula for Young Children During Intubation
NCT06683599Difficult Airway, Difficult Airway Intubation, Neonate
Vinícius C Quintão, MD, MSc, PhD
Not applicable
240
Perth
2024-12-10
Recruiting
BeOne Medicines
Phase 1
168
Blacktown, Liverpool, South Brisbane, Clayton, Malvern
2024-12-09
Active, closed
Vicore Pharma AB
Phase 2
378
Footscray, Adelaide, Brisbane, Concord, Darlinghurst, Douglas, Heidelberg, Sydney
2024-12-09
Active, closed
Hoffmann-La Roche
Phase 2
62
Elizabeth Vale
2024-12-09
Active, closed
Amgen
Phase 3
707
Camperdown, North Ryde, Woolloongabba, Clayton, Melbourne, Murdoch
2024-12-09
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Camperdown, Sydney, Melbourne
2024-12-09
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Camperdown, Herston, Nedlands, North Ryde, Parkville
2024-12-06
Recruiting
Closed-loop in Adults With Type 2 Diabetes
NCT06579404Type 2 Diabetes Treated With Insulin
University of Cambridge
Not applicable
224
Melbourne
2024-12-06
Recruiting
Using Artificial Intelligence to Screen for Hip Dysplasia
NCT06647225Developmental Dysplasia of Hip
Murdoch Childrens Research Institute
Not applicable
240
Parkville
2024-12-06
Recruiting
BMB-101 in Absence Epilepsy and DEE
NCT06401538Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome, Lennox Gastaut Syndrome
DrugBMB-101
Bright Minds Biosciences Pty Ltd
Phase 2
20
Randwick, Herston, Fitzroy, Heidelberg, Melbourne
2024-12-05
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Clayton, Fitzroy, Melbourne, Waratah, Wollongong
2024-12-04
Active, closed
Arrowhead Pharmaceuticals
Phase 1/2
190
Camberwell, Charlestown, Maroochydore, Sydney
2024-12-04
Recruiting
Lumen Bioscience, Inc.
Early Phase 1
12
Maroochydore
2024-12-04
Active, closed
Biogen
Phase 3
132
Parkville VIC, Murdoch, Woolloongabba
2024-12-03
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Adelaide, Clayton, Epping, Liverpool, Nedlands, Waratah
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Liverpool, Westmead, Southport, Melbourne
2024-12-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
2024-12-02
Recruiting
Novo Nordisk A/S
Phase 2
465
Castle Hill, Gosford, Chelmer, Reservoir, St Albans
2024-12-02
Not yet open
Epigenic Therapeutics, Inc
Phase 1
36
Westmead
2024-12-01
Not yet open
Monash University
Observational
45
Melbourne
2024-12-01
By invitation
Hidde van der Ploeg
Not applicable
100
Saint Lucia
2024-12-01
Not yet open
Launceston General Hospital
Observational
100
Launceston
2024-12
Active, closed
Ocular Therapeutix, Inc.
Phase 3
825
Albury, Parramatta
2024-11-27
Recruiting
BeOne Medicines
Phase 1/2
80
Kogarah, South Brisbane, Clayton, Melbourne, Nedlands
2024-11-27
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Heidelberg, Kogarah, Macquarie University, Nedlands
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Darlinghurst, Hyde Park, Southport, Wollongong
2024-11-27
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
Adcendo ApS
Phase 1
210
Macquarie Park, Randwick, Bedford Park, Frankston, Malvern, Melbourne, Nedlands
2024-11-25
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Saint Leonards, South Brisbane, Parkville
2024-11-22
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Fitzroy, Frankston, Sunshine Coast, Campbelltown, Gosford, North Ryde, Concord
2024-11-22
Recruiting
Washington University School of Medicine
Phase 2/3
280
Randwick, Melbourne
2024-11-22
Recruiting
Washington University School of Medicine
Phase 2/3
280
Randwick, Melbourne
2024-11-22
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
50
Nedlands, Parkville, South Brisbane
2024-11-21
Recruiting
International CRDS Registry
NCT06508164Calcium Release Deficiency Syndrome
Population Health Research Institute
Observational
500
Darlinghurst
2024-11-21
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Clayton, Blacktown, Chermside, Bedford Park, Perth
2024-11-20
Active, closed
University of Melbourne
Phase 4
352
Fitzroy, Melbourne
2024-11-19
Active, closed
Daiichi Sankyo
Phase 3
700
Adelaide, Bedford Park, Box Hill, Concord, Darlinghurst, Douglas, Liverpool, Melbourne
2024-11-19
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
386
Sydney
2024-11-18
Active, closed
Cochlear
Not applicable
18
Melbourne
2024-11-18
Recruiting
AstraZeneca
Phase 3
1,160
Darlinghurst, Hyde Park, Southport, Wollongong
2024-11-18
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Camperdown, Macquarie Park, Brisbane, South Brisbane, Box Hill, Nedlands
2024-11-15
Recruiting
Genentech, Inc.
Phase 1
410
Darlinghurst, Mount Kuring-Gai, Parkville
2024-11-14
Recruiting
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection
DrugsDaptomycin·Vancomycin
Todd C. Lee MD MPH FIDSA
Phase 4
300
Blacktown, Concord, Newcastle, Westmead, Herston, Bedford Park, Berwick, Box Hill
2024-11-14
Recruiting
GigaGen, Inc.
Phase 1
48
Concord, Fortitude Valley
2024-11-13
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Concord, Kingswood, Liverpool, Westmead, Clayton, Heidelberg, Parkville, Perth
2024-11-12
Recruiting
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
NCT06462729Degenerative Disc Disease, Lumbar Disc Disease, Spine Disease, Lumbar Spine Degeneration
Locate Bio Pty Ltd
Phase 1/2
40
Newcastle
2024-11-12
Recruiting
Intelligem Therapeutics Australia Pty Ltd.
Phase 1/2
60
Botany, Kotara, Camberwell
2024-11-12
Recruiting
University of Birmingham
Phase 1/2
160
Sydney
2024-11-11
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Randwick, Westmead, Brisbane, Heidelberg, Melbourne, Parkville
2024-11-11
Active, closed
GlaxoSmithKline
Phase 2
283
Westmead, Fitzroy
2024-11-11
Recruiting
Murdoch Childrens Research Institute
Phase 4
40
Melbourne, Sydney
2024-11-10
Recruiting
Bayer
Phase 1
104
Albury, Macquarie Park, Frankston, Malvern
2024-11-08
Active, closed
AbbVie
Phase 2
74
South Brisbane
2024-11-08
Active, closed
Alnylam Pharmaceuticals
Phase 1/2
89
Camperdown, Parkville
2024-11-07
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
NCT07156136PRAME Positive, Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1
140
Adelaide, Nedlands, Wollstonecraft
2024-11-07
Recruiting
Accelerated Flap Coverage in Severe Lower Extremity Trauma
NCT06293469Open Tibia Fracture, Open Dislocation of Ankle, Extremity Fracture Lower, Extremity Injuries Lower
Johns Hopkins University
Not applicable
356
Melbourne
2024-11-04
Recruiting
Pathios Therapeutics Pty Ltd
Phase 1/2
30
Blacktown, Randwick, Adelaide, Heidelberg, Nedlands
2024-11-04
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Sydney, Melbourne, Mount Pleasant
2024-11-03
Not yet open
Launceston General Hospital
Observational
100
Launceston
2024-11-01
Active, closed
Hospital Universitari de Bellvitge
Observational
369
Melbourne
2024-11-01
Recruiting
A Study of DM005 in Patients With Advanced Solid Tumors
NCT06515990Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck, Solid Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd.
Phase 1/2
208
Camperdown, North Ryde, South Brisbane
2024-10-31
Recruiting
Telix Pharmaceuticals (Innovations) Pty Ltd
Phase 1
50
Brisbane, Melbourne, Perth
2024-10-31
Active, closed
SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)
NCT06461286OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies, Kjer Optic Atrophy
DrugPYC-001
PYC Therapeutics
Phase 1
18
Sydney, East Melbourne
2024-10-31
Recruiting
Palette Life Sciences, Inc.
Not applicable
84
Fitzroy, Melbourne
2024-10-31
Recruiting
ModernaTX, Inc.
Phase 1
42
Melbourne
2024-10-31
Recruiting
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
NCT06451770Hypercholesterolemia, Hypertriglyceridemia, Refractory Hyperlipidemia
Verve Therapeutics, Inc.
Phase 1
132
Adelaide, Melbourne
2024-10-30
Active, closed
A Study of ZW191 in Participants With Solid Tumors
NCT06555744Advanced Solid Tumors
Zymeworks BC Inc.
Phase 1
145
Nedlands, St Leonards
2024-10-30
Active, closed
Dren Bio
Phase 1
81
Charlestown, Darlinghurst, Coorparoo, South Yarra, Fremantle
2024-10-30
Active, closed
Sydney Local Health District
Observational
50
Sydney
2024-10-30
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Albury, Hurstville, Strathfield, Adelaide, East Melbourne
2024-10-30
Recruiting
Sanofi
Phase 1
87
Wollongong, Melbourne
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Camperdown, Darlinghurst
2024-10-29
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Nedlands, South Brisbane, Westmead
2024-10-29
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Sydney, Westmead, Auchenflower
2024-10-29
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors
DrugsBBO-10203·Ribociclib·Folfox·Fulvestrant
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
392
Randwick, Melbourne
2024-10-29
Recruiting
Murdoch Childrens Research Institute
Phase 2
232
Sydney, Brisbane, Melbourne, Perth
2024-10-29
Recruiting
Eating Disorders Genetics Initiative 2
NCT06594913Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Avoidant Restrictive Food Intake Disorder
University of North Carolina, Chapel Hill
Observational
20,000
Brisbane
2024-10-28
Active, closed
Eli Lilly and Company
Phase 2
45
Brisbane, Nedlands, Westmead
2024-10-25
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Camperdown, Darlinghurst, New Lambton Heights, Adelaide
2024-10-24
Active, closed
Eli Lilly and Company
Phase 3
1,400
Birtinya, Botany, Box Hill, Camberwell, East Maitland, Herston, Ipswich, Ivanhoe
2024-10-24
Recruiting
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2
202
Wollongong, Birtinya, South Brisbane, Macquarie
2024-10-24
Active, closed
A Study of DM001 in Patients With Advanced Solid Tumors
NCT06475937Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Solid Carcinoma
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Phase 1
128
South Brisbane, Southport, Clayton
2024-10-24
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
56
Adelaide, Liverpool, Melbourne, Woolloongabba
2024-10-23
Rows per page Showing 1001–1500 of 3370
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-australia?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,370 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Australia?

1,816 of the 3,370 studies in this register are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 185 have not yet opened recruitment, 1,294 are active but closed to new participants, and 75 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (67) Multiple Myeloma (60) Advanced Solid Tumor (50) Prostate Cancer (43) Obesity (41) Advanced Solid Tumors (39) Non-Small Cell Lung Cancer (34) Melanoma (33) Chronic Lymphocytic Leukemia (33) Non-small Cell Lung Cancer (28) Healthy Volunteers (26) Carcinoma, Non-Small-Cell Lung (25) Heart Failure (25) Solid Tumors (24) Ovarian Cancer (24)
→

Browse trials by site location

Melbourne (1109) Adelaide (582) Sydney (520) Westmead (421) Clayton (411) Nedlands (381) Brisbane (355) Camperdown (348) Parkville (320) South Brisbane (313) Perth (299) Heidelberg (273) Darlinghurst (246) Woolloongabba (239) Randwick (210)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.